Cargando…

Efficacy of thalidomide for a girl with inflammatory calicinosis, a severe complication of juvenile dermatomyosistis

Detalles Bibliográficos
Autores principales:	Miyamae, T, Kikuchi, M, Kasai, K, Hara, R, Kaneko, U, Shinoki, T, Imagawa, T, Mori, M, Yokota, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334028/ http://dx.doi.org/10.1186/1546-0096-6-S1-P223

Ejemplares similares

Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis
por: Miyamae, Takako, et al.
Publicado: (2010)

Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy
por: Hara, Ryoki, et al.
Publicado: (2011)

IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
por: Yokota, S, et al.
Publicado: (2003)

Fever without apparent sources in children: a nation-wide study in Japan
por: Kasai, K, et al.
Publicado: (2008)

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
por: Miyamae, Takako, et al.
Publicado: (2011)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
por: Yokota, S, et al.
Publicado: (2008)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
por: Alpigiani, MG, et al.
Publicado: (2008)

PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis
por: Hisa, Kaori, et al.
Publicado: (2017)

PReS-FINAL-2172: Efficacy of corticosteroids and intravenous cyclophosphamide for patients with juvenile systemic sclerosis
por: Kikuchi, M, et al.
Publicado: (2013)

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
por: Sato, T, et al.
Publicado: (2013)

PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy
por: Yamazaki, K, et al.
Publicado: (2013)

PW02-024 - A case of candle syndrome treated with thalidomide
por: Yamazaki, K, et al.
Publicado: (2013)

Effect of anakinra on arthropathy in CINCA/NOMID syndrome
por: Miyamae, Takako, et al.
Publicado: (2010)

PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
por: Yokota, S, et al.
Publicado: (2013)

Thalidomide inhibits inflammation and angiogenesis in tumor 4T1 growth in mice
por: Souza, Cristina M, et al.
Publicado: (2013)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Efficacy and safety of thalidomide in two sisters with severe refractory polyarteritis nodosa (PAN)
por: Vitale, A, et al.
Publicado: (2008)

PReS-FINAL-2125: A Japanese girl with childhood-onset anti-Ku antibody positive generalized morphea-myositis overlap syndrome
por: Kishi, T, et al.
Publicado: (2013)

Analysis of Gender Differences in Genetic Risk: Association of TNFAIP3 Polymorphism with Male Childhood-Onset Systemic Lupus Erythematosus in the Japanese Population
por: Kadota, Keisuke, et al.
Publicado: (2013)

Refractory systemic juvenile idiopathic arthritis complicated by coxarthrosis
por: Mellos, Antonio, et al.
Publicado: (2014)

Psychiatric symptoms as the first manifestation of juvenile SLE complicated with Klinefelter's syndrome
por: Yeganeh, Mehrnoush Hassas, et al.
Publicado: (2014)

Macrophage activation syndrome: an under-recognised complication in juvenile systemic lupus erythematosus
por: Sundaramoorthy, C, et al.
Publicado: (2008)

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
por: Pagnini, I, et al.
Publicado: (2013)

Macrophage activation syndrome (MAS) in juvenile systemic lupus erythematosus (JSLE): an underrecognized complication?
por: Parodi, A, et al.
Publicado: (2008)

Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
por: Bader-Meunier, B, et al.
Publicado: (2011)

A difficult case of juvenile dermatomyositis complicated by thrombotic microangiopathy and purtscher-like retinopathy
por: Vanoni, Federica, et al.
Publicado: (2014)

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
por: De Benedetti, Fabrizio, et al.
Publicado: (2014)

Thalidomide modulates macrophage-mediated inflammatory innate immune response during Klebsiella pneumoniae B5055 infection in BALB/c mice
por: Kumar, V, et al.
Publicado: (2012)

Thalidomide exerts protective immunomodulatory action during Klebsiella pneumoniae B5055-induced acute lung infection in BALB/c mice
por: Kumar, V, et al.
Publicado: (2014)

Thalidomide in combination with augmentin (amoxicillin with clavulanic acid) protects BALB/c mice suffering from Klebsiella pneumoniae B5055-induced sepsis
por: Kumar, V, et al.
Publicado: (2011)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Davì, Sergio, et al.
Publicado: (2011)

Posterior reversible encephalopathy syndrome complicating macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis
por: Tsinti, Maria, et al.
Publicado: (2014)

Prevalence of polymorphisms of the genes responsible for auto-inflammatory diseases among 236 patients with recurrent fever in a rheumatology institute in Japan
por: Miyamae, T, et al.
Publicado: (2015)

PReS-FINAL-2046: Uveitis in the Nordic juvenile idiopathic arthritis cohort; high incidence, frequent complications, and gender-associated risk factors
por: Nordal, EB, et al.
Publicado: (2013)

Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients
por: Aikawa, Nadia E, et al.
Publicado: (2012)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

The prospective juvenile systemic sclerosis inceptions cohort – http://www.juvenile-scleroderma.com
por: Foeldvari, I, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_efomco3frub567sq064cpkrttf